Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Releases Earnings Results

Shionogi & Co., Ltd. (OTCMKTS:SGIOYGet Free Report) posted its quarterly earnings data on Friday. The company reported $0.16 earnings per share (EPS) for the quarter, Zacks reports. Shionogi & Co., Ltd. had a net margin of 35.53% and a return on equity of 11.95%.

Shionogi & Co., Ltd. Stock Up 1.4 %

OTCMKTS SGIOY traded up $0.10 during trading on Friday, hitting $7.42. The company’s stock had a trading volume of 98,808 shares, compared to its average volume of 218,618. Shionogi & Co., Ltd. has a 52 week low of $6.22 and a 52 week high of $9.11. The firm has a 50 day moving average price of $7.07 and a 200 day moving average price of $8.59. The firm has a market cap of $12.62 billion, a P/E ratio of 12.65, a price-to-earnings-growth ratio of 2.39 and a beta of 0.21.

About Shionogi & Co., Ltd.

(Get Free Report)

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.

Read More

Earnings History for Shionogi & Co., Ltd. (OTCMKTS:SGIOY)

Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.